| Microfluidics‐based 3D cell culture models: Utility in novel drug discovery and delivery research N Gupta, JR Liu, B Patel, DE Solomon, B Vaidya, V Gupta Bioengineering & translational medicine 1 (1), 63-81, 2016 | 232 | 2016 |
| In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals K Nahar, N Gupta, R Gauvin, S Absar, B Patel, V Gupta, ... European journal of pharmaceutical sciences 49 (5), 805-818, 2013 | 159 | 2013 |
| Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome B Patel, N Gupta, F Ahsan European Journal of Pharmaceutics and Biopharmaceutics 89, 163-174, 2015 | 156 | 2015 |
| Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension V Gupta, N Gupta, IH Shaik, R Mehvar, IF McMurtry, M Oka, ... Journal of controlled release 167 (2), 189-199, 2013 | 127 | 2013 |
| Nano-engineered erythrocyte ghosts as inhalational carriers for delivery of fasudil: preparation and characterization N Gupta, B Patel, F Ahsan Pharmaceutical Research 31 (6), 1553-65, 2014 | 93 | 2014 |
| Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective D Solomon, N Gupta, NS Mulla, S Shukla, YA Guerrero, V Gupta The AAPS journal 19, 1669-1681, 2017 | 78 | 2017 |
| Exploring potential of quantum dots as dual modality for cancer therapy and diagnosis NS Kulkarni, Y Guererro, N Gupta, A Muth, V Gupta Journal of drug delivery science and technology 49, 352-364, 2019 | 56 | 2019 |
| Fasudil and SOD packaged in peptide-studded-liposomes: properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs N Gupta, FI Al-Saikhan, B Patel, J Rashid, F Ahsan International journal of pharmaceutics 488 (1-2), 33-43, 2015 | 50 | 2015 |
| Peptide-coated liposomal fasudil enhances site specific vasodilation in pulmonary arterial hypertension K Nahar, S Absar, N Gupta, VR Kotamraju, IF McMurtry, M Oka, ... Molecular pharmaceutics 11 (12), 4374-4384, 2014 | 48 | 2014 |
| Peptide–micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension N Gupta, HM Ibrahim, F Ahsan Journal of Pharmaceutical Sciences 103 (11), 3743-3753, 2014 | 47 | 2014 |
| Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy S Absar, N Gupta, K Nahar, F Ahsan Journal of Thrombosis and Haemostasis 13 (9), 1545-1556, 2015 | 39 | 2015 |
| Cell permeable peptide conjugated nanoerythrosomes of fasudil prolong pulmonary arterial vasodilation in PAH rats N Gupta, B Patel, K Nahar, F Ahsan European Journal of Pharmaceutics and Biopharmaceutics 88 (3), 1046-1055, 2014 | 38 | 2014 |
| Inhaled PLGA Particles of Prostaglandin E1 Ameliorate Symptoms and Progression of Pulmonary Hypertension at a Reduced Dosing Frequency V Gupta, N Gupta, IH Shaik, R Mehvar, E Nozik-Grayck, IF McMurtry, ... Molecular pharmaceutics 10 (5), 1655-1667, 2013 | 32 | 2013 |
| Cocktail of superoxide dismutase and fasudil encapsulated in targeted liposomes slows PAH progression at a reduced dosing frequency N Gupta, J Rashid, E Nozik-Grayck, IF McMurtry, KR Stenmark, F Ahsan Molecular pharmaceutics 14 (3), 830-841, 2017 | 28 | 2017 |
| Evaluation of Wound healing activity of Tinospora cordifolia Willd A Nema Der Pharmacia Sinica, 2012 | 23 | 2012 |
| Newer devices and improved formulations of inhaled insulin J Rashid, S Absar, K Nahar, N Gupta, F Ahsan Expert Opinion on Drug Delivery 12 (6), 917-928, 2015 | 22 | 2015 |
| Computational and bioengineered lungs as alternatives to whole animal, isolated organ, and cell-based lung models B Patel, R Gauvin, S Absar, V Gupta, N Gupta, K Nahar, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 303 (9 …, 2012 | 22 | 2012 |
| Low-molecular-weight heparin (LMWH)–loaded large porous PEG-PLGA particles for the treatment of asthma B Patel, N Gupta, F Ahsan Journal of aerosol medicine and pulmonary drug delivery 27 (1), 12-20, 2014 | 21 | 2014 |
| Accelerated repurposing and drug development of pulmonary hypertension therapies for COVID-19 treatment using an AI-integrated biosimulation platform K Chakravarty, VG Antontsev, M Khotimchenko, N Gupta, A Jagarapu, ... Molecules 26 (7), 1912, 2021 | 19 | 2021 |
| Aerosolized montelukast polymeric particles—an alternative to oral montelukast–alleviate symptoms of asthma in a rodent model B Patel, N Gupta, F Ahsan Pharmaceutical research 31, 3095-3105, 2014 | 18 | 2014 |
